{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T23:08:31Z","timestamp":1761260911284,"version":"build-2065373602"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,23]]},"DOI":"10.7759\/cureus.95255","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T23:03:48Z","timestamp":1761260628000},"source":"Crossref","is-referenced-by-count":0,"title":["Romosozumab-Induced Epidural Calcification in a Hemodialysis Patient"],"prefix":"10.7759","author":[{"given":"Satoshi","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-009-0020-6","article-title":"Point: hydroxyapatite crystal deposition is intimately involved in the pathogenesis and progression of human osteoarthritis","volume":"11","author":"McCarthy GM","year":"2009","unstructured":"McCarthy GM, Cheung HS. Point: hydroxyapatite crystal deposition is intimately involved in the pathogenesis and progression of human osteoarthritis. Curr Rheumatol Rep. 2009, 11:141-147. 10.1007\/s11926-009-0020-6","journal-title":"Curr Rheumatol Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag KG","year":"2017","unstructured":"Saag KG, Petersen J, Brandi ML, et al.. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med. 2017, 377:1417-1427. 10.1056\/NEJMoa1708322","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093199","article-title":"The role of sclerostin in bone and ectopic calcification","volume":"21","author":"Mar\u00e9 A","year":"2020","unstructured":"Mar\u00e9 A, D'Haese PC, Verhulst A. The role of sclerostin in bone and ectopic calcification. Int J Mol Sci. 2020, 21:3199. 10.3390\/ijms21093199","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65313-8","article-title":"Ectopic calcification: gathering hard facts about soft tissue mineralization","volume":"154","author":"Giachelli CM","year":"1999","unstructured":"Giachelli CM. Ectopic calcification: gathering hard facts about soft tissue mineralization. Am J Pathol. 1999, 154:671-675. 10.1016\/S0002-9440(10)65313-8","journal-title":"Am J Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14749","article-title":"Rationales of delay and difference in regulatory review by Japan, the USA and Europe among new drugs first approved in Japan","volume":"87","author":"Tanaka M","year":"2021","unstructured":"Tanaka M, Idei M, Sakaguchi H, et al.. Rationales of delay and difference in regulatory review by Japan, the USA and Europe among new drugs first approved in Japan. Br J Clin Pharmacol. 2021, 87:3279-3291. 10.1111\/bcp.14749","journal-title":"Br J Clin Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-024-02921-5","article-title":"Romosozumab adverse event profile: a pharmacovigilance analysis based on the FDA Adverse Event Reporting System (FAERS) from 2019 to 2023","volume":"37","author":"Liu L","year":"2025","unstructured":"Liu L, Wu S, Wei L, Xia Z, Ji J, Huang D. Romosozumab adverse event profile: a pharmacovigilance analysis based on the FDA Adverse Event Reporting System (FAERS) from 2019 to 2023. Aging Clin Exp Res. 2025, 37:23. 10.1007\/s40520-024-02921-5","journal-title":"Aging Clin Exp Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.CC.23.00484","article-title":"Myositis ossificans of the psoas major muscle after XLIF with preoperative administration of romosozumab: a case report","volume":"14","author":"Ito T","year":"2024","unstructured":"Ito T, Katsumi S, Shinohara A, Arimura D, Obata S, Ikegami T, Saito M. Myositis ossificans of the psoas major muscle after XLIF with preoperative administration of romosozumab: a case report. JBJS Case Connect. 2024, 14:10.2106\/JBJS.CC.23.00484","journal-title":"JBJS Case Connect"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-18790-2_8","article-title":"Diagnosis of soft tissue calcification","author":"Elgazzar AH","year":"2004","unstructured":"Elgazzar AH. Diagnosis of soft tissue calcification. Orthopedic Nuclear Medicine. Springer, Berlin, Heidelberg; 2004. 197-210. 10.1007\/978-3-642-18790-2_8"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.43.5.734","article-title":"Histopathological and ultrastructural studies of synovium in Milwaukee shoulder syndrome\u2014a basic calcium phosphate crystal arthropathy","volume":"43","author":"Halverson PB","year":"1984","unstructured":"Halverson PB, Garancis JC, McCarty DJ. Histopathological and ultrastructural studies of synovium in Milwaukee shoulder syndrome\u2014a basic calcium phosphate crystal arthropathy. Ann Rheum Dis. 1984, 43:734-741. 10.1136\/ard.43.5.734","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-022-01031-6","article-title":"One-year romosozumab treatment followed by one-year denosumab treatment for osteoporosis in patients on hemodialysis: an observational study","volume":"112","author":"Saito T","year":"2023","unstructured":"Saito T, Mizobuchi M, Kato T, et al.. One-year romosozumab treatment followed by one-year denosumab treatment for osteoporosis in patients on hemodialysis: an observational study. Calcif Tissue Int. 2023, 112:34-44. 10.1007\/s00223-022-01031-6","journal-title":"Calcif Tissue Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000355204","article-title":"Anti-osteoporotic drugs and vascular calcification: the bidirectional calcium traffic","volume":"51","author":"Yavropoulou MP","year":"2014","unstructured":"Yavropoulou MP, Pikilidou M, Yovos JG. Anti-osteoporotic drugs and vascular calcification: the bidirectional calcium traffic. J Vasc Res. 2014, 51:37-49. 10.1159\/000355204","journal-title":"J Vasc Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2006.00345.x","article-title":"Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects","volume":"10","author":"Hashiba H","year":"2006","unstructured":"Hashiba H, Aizawa S, Tamura K, Kogo H. Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects. Ther Apher Dial. 2006, 10:59-64. 10.1111\/j.1744-9987.2006.00345.x","journal-title":"Ther Apher Dial"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.12.039","article-title":"Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial","volume":"56","author":"Toussaint ND","year":"2010","unstructured":"Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG. Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial. Am J Kidney Dis. 2010, 56:57-68. 10.1053\/j.ajkd.2009.12.039","journal-title":"Am J Kidney Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.14932\/jamt.23-124","article-title":"Examination of joint fluid diagnostic staining method for hydroxyapatite deposition disease (article in Japanese)","volume":"73","author":"Hachisuka D","year":"2024","unstructured":"Hachisuka D, Nakanishi T, Twasaki T, et al.. Examination of joint fluid diagnostic staining method for hydroxyapatite deposition disease (article in Japanese). Jpn J Med Technol. 2024, 73:719-725. 10.14932\/jamt.23-124","journal-title":"Jpn J Med Technol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/424956-romosozumab-induced-epidural-calcification-in-a-hemodialysis-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T23:03:59Z","timestamp":1761260639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/424956-romosozumab-induced-epidural-calcification-in-a-hemodialysis-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.95255","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,10,23]]}}}